AI Product
Anumana — Digital Health
ECG-AI software-as-a-medical-device algorithms analyzing standard 12-lead ECG waveforms to detect low ejection fraction, pulmonary hypertension, cardiac amyloidosis, and additional cardiovascular conditions in development.
- Status
- Active
- Category
- Digital Health
- Developer
- Anumana
- Industry
- AI in Healthcare
- Country
- United States
Product Ecosystem Map
How this product connects across company, capabilities, technology, and markets on Brel.
Overview
What this product is, what it does, and who develops it.
Headquartered in Cambridge, United States, Anumana built Anumana — Digital Health to provide specialized automation for technical teams, data leaders, and operational specialists in Healthcare. The software tackles clinical workflow latency and diagnostic data fragmentation through continuous correlating genomic sequencing profiles against clinical outcome registries.
Cambridge ECG-AI company detecting hidden cardiovascular conditions from standard 12-lead electrocardiograms
What it does
ECG-AI software-as-a-medical-device algorithms analyzing standard 12-lead ECG waveforms to detect low ejection fraction, pulmonary hypertension, cardiac amyloidosis, and additional cardiovascular conditions in development.
Who develops it
Health systems, cardiologists, and primary care networks performing high-volume ECGs who need early detection of heart failure risk, pulmonary hypertension, and amyloidosis without adding separate diagnostic tests at point of care.
Capabilities & Features
Verified capabilities and product features from the Brel product record.
Capabilities
- ECG-AI software-as-a-medical-device algorithms analyzing standard 12-lead ECG waveforms to detect low ejection fraction, pulmonary hypertension, cardiac amyloidosis, and additional cardiovascular conditions in development.
Technology & Architecture
Technologies, models, and technical structure linked to this product.
At the algorithmic level, Anumana — Digital Health utilizes Healthcare Analytics, Machine Learning, Deep Learning, Predictive Analytics, Medical Imaging to power its analysis and synthesis engines. The system enforces strict boundary conditions to guarantee reliable model inference at enterprise scale. For comprehensive background on these AI methodologies, see Brel's guides to Machine Learning, Deep Learning.
Use Cases
Where this product is applied in real operational contexts.
- ECG-AI software-as-a-medical-device algorithms analyzing standard 12-lead ECG waveforms to detect low ejection fraction, pulmonary hypertension, cardiac amyloidosis, and additional cardiovascular conditions in development.
- Medical Imaging: Optimizing workflow execution latency and improving throughput.
Who It Is For
Target users, industries, and deployment context.
Health systems, cardiologists, and primary care networks performing high-volume ECGs who need early detection of heart failure risk, pulmonary hypertension, and amyloidosis without adding separate diagnostic tests at point of care.
Industries
Industries served
- AI in Healthcare
- Digital Health
Designed with technical teams, data leaders, and operational specialists in Healthcare in mind, Anumana — Digital Health streamlines daily execution while preserving IT governance. Organizations can roll out the software across air-gapped biomedical research clusters with encrypted enclaves with minimal infrastructure disruption.
Integrations & Deployment
Integration surface and how the product is deployed.
Enterprises can integrate Anumana — Digital Health into existing operational stacks via modular connectors, secure webhooks, and programmatic SDKs. This ensures cohesive synchronization between the AI platform and downstream reporting systems.
Developer
API, documentation, GitHub, and technical resources when verified.
Developer / Company
The organization that builds and ships this product.
Frequently Asked Questions
Answers restated from verified fields on this product profile.
What does Anumana — Digital Health offer?
Anumana — Digital Health is an AI solution developed by Anumana, designed to deliver optimizing clinical department throughput while lowering documentation fatigue by systematizing correlating genomic sequencing profiles against clinical outcome registries.
What company operates Anumana — Digital Health?
Anumana — Digital Health is built and maintained by Anumana, based in Cambridge, United States.
What functional features does Anumana — Digital Health provide?
Documented capabilities include: device algorithms analyzing standard 12; lead ECG waveforms to detect low ejection fraction, pulmonary hypertension, cardiac amyloidosis, and additional cardiovascular conditions in development; Anumana's models apply deep learning to ECG voltage signals, extracting features invisible to standard visual reads.
How does Anumana — Digital Health utilize artificial intelligence?
Anumana — Digital Health utilizes Machine Learning, Deep Learning, Predictive Analytics, Medical Imaging, Healthcare Analytics, supporting deployment across HIPAA-compliant private cloud partitions.
Who is Anumana — Digital Health intended for?
The software is engineered for Health systems, cardiologists, and primary care networks performing high-volume ECGs who need early detection of heart failure risk, pulmonary hypertension, and amyloidosis without adding separate diagnostic tests at point of care. seeking to mitigate inconsistent pathological classification and clinical documentation burden.
Sources & Verification
Primary sources
Request a correction if you represent this company or believe information is inaccurate.
Related Knowledge
Evergreen architectural research, conceptual foundations, and technical reference guides from the Brel Knowledge Library.